Abbott Laboratories Stock Reacts to Q4 Metrics Abbott reported Q4 revenue of about $10.8B (Feb 2026); stock and a ~1.8% dividend yield faced scrutiny as markets reassess device growth vs diagnostic headwinds.

Abbott Laboratories Stock Reacts to Q4 Metrics: Abbott reported Q4 revenue of about $10.8B (Feb 2026); stock and a ~1.8% dividend yield faced scrutiny as markets reassess device growth vs diagnostic headwinds. Read full analysis 👉 #AbbottLaboratories #StockMarket #Quarter4 #FinanceNews #Investing